ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $37,000 | -83.8% | 14,700 | -85.2% | 0.00% | -83.3% |
| Q4 2018 | $229,000 | +45.9% | 99,167 | +36.0% | 0.01% | +100.0% |
| Q2 2017 | $157,000 | -39.8% | 72,892 | -12.1% | 0.00% | -50.0% |
| Q1 2017 | $261,000 | -3.0% | 82,914 | -19.8% | 0.01% | -40.0% |
| Q4 2016 | $269,000 | -0.7% | 103,420 | +48.7% | 0.01% | +25.0% |
| Q3 2016 | $271,000 | -34.5% | 69,554 | -54.8% | 0.01% | -42.9% |
| Q2 2016 | $414,000 | -68.4% | 153,769 | -63.8% | 0.01% | -62.2% |
| Q1 2016 | $1,309,000 | -23.8% | 425,142 | -3.5% | 0.04% | -9.8% |
| Q4 2015 | $1,718,000 | – | 440,485 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |